160 Boots and 130 Lloydspharmacies among those eligible for monthly funding top-ups

More than a quarter of the pharmacies eligible for monthly funding top-ups under the revised PhAS belong to the four biggest multiples, however, a new payment scheme is designed to “encourage growth for smaller pharmacies”.

Over 1,400 pharmacies in England are eligible for monthly cash top-ups under the Pharmacy Access Scheme (PhAS)
A new payment model aims to "encourage growth for smaller pharmacies and minimise reliance on this additional support for larger pharmacies"

A total of 1,405 pharmacies in England are eligible to receive up to £17,500 a year under the revised Pharmacy Access Scheme (PhAS), which was announced alongside the outcome of negotiations for year three of the community pharmacy contractual framework.

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment0

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment4

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment3

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.